Carbamyl-phosphate-synthetase deficiency with neonatal onset of symptoms.
Acta Paediatr Scand
Published: July 1977
The clinical course and biochemical findings in a case of carbamyl-phosphate-synthetase deficiency are described. The patient, a boy, presented 48 h after birth with rapidly developing hypotonia and hypothermia. Pulmonary haemorrhage, melaena and haematemesis ensued and despite ventilatory assistance and peritoneal dialysis the patient died on the fifth day. A virtual absence of carbamyl phosphate synthetase I (N-acetylglutamate dependent) was proved by analysis of tissue samples removed post mortem. Other urea cycle enzymes were normal.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1651-2227.1977.tb07940.x | DOI Listing |
Similar Publications
Living-Donor Liver Transplantation in a Carbamoyl Phosphate Synthetase I Deficiency Recipient With Scoliosis: A Case Report.
Pediatr Transplant
December 2024
Organ Transplantation Center, National Center for Child Health and Development, Tokyo, Japan.
Article Synopsis
- * A 13-year-old girl with carbamoyl phosphate synthetase I (CPS1) deficiency underwent liver transplantation from her mother, facing significant challenges due to her severe scoliosis which led to portal vein complications necessitating multiple surgical interventions.
- * The case highlights the importance of meticulous preoperative assessments and tailored surgical strategies for patients with structural abnormalities to prevent complications and ensure successful outcomes.
Clinical features and CPS1 variants in Chinese patients with carbamoyl phosphate synthetase 1 deficiency.
BMC Pediatr
August 2024
Children's Medical Center, Peking University First Hospital, Beijing, 102600, China.
Background: Carbamoyl phosphate synthetase 1 (CPS1) deficiency (OMIM 237300), an autosomal recessive rare and severe urea cycle disorder, is associated with hyperammonemia and high mortality.
Methods: Herein we present 12 genetic variants identified in seven clinically well-characterized Chinese patients with CPS1 deficiency who were admitted to the Children's Medical Center of Peking University First Hospital from September 2014 to August 2023.
Results: Seven patients (two male and five female patients including two sisters) experienced symptoms onset between 2 days and 13 years of age, and they were diagnosed with CPS1 deficiency between 2 months and 20 years.
A successful liver transplantation in a patient with neonatal-onset carbamoyl phosphate synthetase-1 deficiency.
J Pediatr Endocrinol Metab
October 2024
Liver Transplantation Center, Memorial Atasehir/Bahçelievler Hospitals, Istanbul, Türkiye.
Article Synopsis
- Carbamoyl phosphate synthetase 1 (CPS-1) deficiency is a rare urea cycle disorder affecting approximately 1 in 150,000-200,000 newborns, often causing severe hyperammonemia shortly after protein intake, leading to high mortality rates in early-onset cases.
- A case study of a newborn male with elevated ammonia levels due to CPS-1 deficiency shows he received urgent treatments, including dextrose infusion, ammonia-scavenging therapy, peritoneal dialysis, and ultimately, a liver transplant from his father at six months of age.
- The study highlights the potential benefits of liver transplantation in CPS-1 deficiency cases and suggests that carglumic acid could improve long-term
Use of pure recombinant human enzymes to assess the disease-causing potential of missense mutations in urea cycle disorders, applied to N-acetylglutamate synthase deficiency.
J Inherit Metab Dis
November 2024
Instituto de Biomedicina de Valencia, IBV-CSIC, Valencia, Spain.
N-acetylglutamate synthase (NAGS) makes acetylglutamate, the essential activator of the first, regulatory enzyme of the urea cycle, carbamoyl phosphate synthetase 1 (CPS1). NAGS deficiency (NAGSD) and CPS1 deficiency (CPS1D) present identical phenotypes. However, they must be distinguished, because NAGSD is cured by substitutive therapy with the N-acetyl-L-glutamate analogue N-carbamyl-L-glutamate, while curative therapy of CPS1D requires liver transplantation.
View Article and Find Full Text PDFImpact of citrulline substitution on clinical outcome after liver transplantation in carbamoyl phosphate synthetase 1 and ornithine transcarbamylase deficiency.
J Inherit Metab Dis
March 2024
Department of Paediatrics I, Medical University of Innsbruck, Innsbruck, Austria.
Carbamoyl phosphate synthetase 1 (CPS1) and ornithine transcarbamylase (OTC) deficiencies are rare urea cycle disorders, which can lead to life-threatening hyperammonemia. Liver transplantation (LT) provides a cure and offers an alternative to medical treatment and life-long dietary restrictions with permanent impending risk of hyperammonemia. Nevertheless, in most patients, metabolic aberrations persist after LT, especially low plasma citrulline levels, with questionable clinical impact.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!
© LitMetric 2025. All rights reserved.